Slingshot members are tracking this event:
FDA Approves Celgene's (CELG) REVLIMID in Treating Multiple Myeloma (MM) Following Autologous Stem Cell Transplant (ASCT)
Slingshot Insights Explained
Feb 22, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Revlimid, Multiple Myeloma, Autologous Stem Cell Transplant